某三甲医院2023年万古霉素血清药物浓度检测情况及合理用药分析
Therapeutic Drug Monitoring and Rationality Analysis of Vancomycin Use in a Tertiary Hospital in 2023
DOI: 10.12677/pi.2025.141006, PDF,   
作者: 张 懿*：长沙市第四医院药学部(湖南师范大学附属长沙医院药学部)，湖南 长沙；杨中保：长沙市第四医院药学部(湖南师范大学附属长沙医院药学部)，湖南 长沙；湖南师范大学医学院，湖南 长沙；宋慧玲：湖南师范大学医学院，湖南 长沙
关键词: 万古霉素；血清药物浓度监测；临床药学；合理用药；Vancomycin； Therapeutic Drug Monitoring； Clinical Pharmacy； Rational Drug Use
摘要: 目的：评价本院万古霉素血药浓度监测(therapeutic drug monitoring, TDM)结果和临床应用情况。方法：回顾性收集2023年在我院使用万古霉素并检测血药浓度患者的临床资料，并结合检测结果和临床应用评价万古霉素的用药合理性。结果：136例患者共报告万古霉素TDM 184例次，患者平均给药(5.29 ± 3.5) d后首次进行TDM检测，37.30%患者监测结果在10~20 μg/mL范围内。28例次检测结果超过危急值(30 μg/mL)，其中5位患者发生肾功能损害。结论：本院万古霉素应用过程中存在标本送检偏晚、联合用药不合理以及万古霉素浓度达标率低等问题。使用万古霉素需加强血药浓度监测，并结合患者的临床情况选择适当的给药方案进行个性化治疗。
Abstract: Objective: To evaluate the therapeutic drug monitoring (TDM) of vancomycin and its clinical application in our hospital. Methods: Clinical data of patients used vancomycin in our hospital in 2023 were retrospectively collected, and the rationality of vancomycin was evaluated by combining the test results and clinical application. Results: A total of 136 patients were included, vancomycin TDM was reported in 184 cases. An average of (5.29 ± 3.5) days of administration followed by the first vancomycin TDM test. 37.30% of patients had monitoring results within the range of 10~20 μg/mL. 28 test results exceeded the critical value (30 μg/mL), with 5 patients occurred acute kidney injury. Conclusion: The challenges of vancomycin used in our hospital include, delays in TDM specimen collection, unreasonable combination therapy and low compliance rate of vancomycin concentration. The use of vancomycin requires enhanced monitoring of blood concentrations and the selection of appropriate dosing regimens for individualized treatment in conjunction with the patient’s clinical situation.
文章引用：张懿, 杨中保, 宋慧玲. 某三甲医院2023年万古霉素血清药物浓度检测情况及合理用药分析[J]. 药物资讯, 2025, 14(1): 58-64. https://doi.org/10.12677/pi.2025.141006

参考文献

[1] 中华人民共和国卫生部. 抗菌药物临床应用指导原则(2015版). 国卫办医发〔2015〕43号附件[EB/OL].
https://www.gov.cn/xinwen/2015-08/27/content_2920799.htm, 2015-07-24.
[2] Cardile, A.P., Tan, C., Lustik, M.B., Stratton, A.N., Madar, C.S., Elegino, J., et al. (2015) Optimization of Time to Initial Vancomycin Target Trough Improves Clinical Outcomes. SpringerPlus, 4, Article No. 364. [Google Scholar] [CrossRef] [PubMed]
[3] 王珏, 马珊, 常青. 万古霉素对老年患者肾毒性的观察及血药浓度监测的意义[J]. 中国基层医药, 2006, 13(12): 1984-1986.
[4] 李刚, 朱以翠, 黎庆萍. 万古霉素相关肾毒性的观察及血药浓度监测的意义[J]. 中国生化药物杂志, 2015, 35(3): 85-88.
[5] 万古霉素临床应用专家组. 万古霉素临床应用中国专家共识(2011版) [J]. 中国新药与临床杂志, 2011, 30(8): 561-573.
[6] 何娜, 苏珊, 翟所迪, 等. 中国万古霉素治疗药物监测指南(2020更新版) [J]. 临床药物治疗杂志, 2021, 19(1): 12-16.
[7] 范亚新, 郭蓓宁. 万古霉素治疗严重耐甲氧西林金黄色葡萄球菌感染的治疗药物监测: 2020年美国卫生系统药师协会、美国感染病学会、儿童感染性疾病学会和感染病药师学会更新修订的共识指南[J]. 中国感染与化疗杂志, 2021, 21(3): 374-376.
[8] 王瑞颖, 易柳, 郭宇鸽, 等. 万古霉素血药浓度快速监测方案的构建与应用[J]. 海峡药学, 2020, 32(9): 48-51.
[9] 孙秀漫, 朱协坤, 周楚娟, 等. 建立适用于联合用药多的患者万古霉素血药浓度监测的HPLC-DAD法[J]. 今日药学, 2021, 31(2): 135-139.
[10] van Hal, S.J., Paterson, D.L. and Lodise, T.P. (2013) Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams Per Liter. Antimicrobial Agents and Chemotherapy, 57, 734-744. [Google Scholar] [CrossRef] [PubMed]
[11] 潘坤明, 李艳丽, 徐辰祺, 等. 1106例万古霉素血药浓度监测及影响因素分析[J]. 医药导报, 2024, 43(2): 184-188.
[12] 孙秀漫, 朱协坤, 周楚娟, 等. 万古霉素联合亚胺培南西司他丁钠或美罗培南抗感染治疗的急性肾损伤发生率的回顾性分析[J]. 中国医院药学杂志, 2024, 44(4): 447-479.
[13] 陈泳伍, 张圣雨, 胡晓文, 等. 两性霉素B脂质体致急性肾损伤相关危险因素分析[J]. 医药导报, 2021, 40(3): 416-419.
[14] 王明明, 朱志会, 楚建杰, 等. 某院万古霉素临床使用合理性分析[J]. 西北药学杂志, 2018, 33(5): 701-705.
[15] 吴月圆, 戴小花, 韩强, 等. 150例次腹膜透析相关腹膜炎病原菌耐药性及预后分析[J]. 医药导报, 2024, 43(2): 287-291.
[16] 刘超梅, 闫晓芳, 宿瑞俊, 等. 临床常见多重耐药菌分布特点及耐药性[J]. 中国国境卫生检疫杂志, 2024, 47(1): 92-94.
[17] 何娜, 邱萌, 闫盈盈, 等. 225例万古霉素针对性抗感染治疗的回顾性分析[J]. 中国临床药理学杂志, 2018, 34(16): 1993-1996.
[18] 陆梦霞, 林维娜, 贺春晖. 老年重症感染患者肾功能与万古霉素血药浓度的相关性[J]. 中国老年学杂志, 2023, 40(5): 1030-1033.
[19] Zonozi, R., Wu, A., Shin, J., Secora, A., Coresh, J., Inker, L.A., et al. (2019) Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis. Mayo Clinic Proceedings, 94, 17-26. [Google Scholar] [CrossRef] [PubMed]
[20] 徐红艳, 马菲, 邓琴香, 等. 万古霉素相关急性肾损伤及肾功能未恢复危险因素分析[J]. 中国药业, 2024, 33(4): 114-118.
[21] Oh, S.J., Hong, K., Lee, E.J., Choi, H.J., Kong, K.A., Lee, M., et al. (2014) Assessment of Therapeutic Drug Monitoring of Vancomycin in Elderly Patients According to New Guidelines. Annals of Laboratory Medicine, 34, 1-6. [Google Scholar] [CrossRef] [PubMed]
[22] 黄魏, 李逃明, 路经纬, 等. 基于集成学习的万古霉素血药浓度及不良反应预测研究[J]. 中南药学, 2024, 22(6): 1645-1651.